Next Article in Journal
Real-Life Safety Profile of the 9-Valent HPV Vaccine Based on Data from the Puglia Region of Southern Italy
Next Article in Special Issue
Effectiveness of mRNA COVID-19 Vaccination on SARS-CoV-2 Infection and COVID-19 in Sicily over an Eight-Month Period
Previous Article in Journal
Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study
Previous Article in Special Issue
Adverse Reactions to Anti-SARS-CoV-2 Vaccine: A Prospective Cohort Study Based on an Active Surveillance System
 
 
Review
Peer-Review Record

Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines

Vaccines 2022, 10(3), 418; https://doi.org/10.3390/vaccines10030418
by Prisca Benedicto-Matambo 1,2,3, Julie E. Bines 4, Chikondi Malamba-Banda 1,2,3,5, Isaac T. Shawa 1,3, Kayla Barnes 1,6, Arox W. Kamng’ona 1,7, Daniel Hungerford 2,8, Kondwani C. Jambo 1,9, Miren Iturriza-Gomara 2,8,10, Nigel A. Cunliffe 2,8, Katie L. Flanagan 11,12,13 and Khuzwayo C. Jere 1,2,3,8,*
Reviewer 1:
Reviewer 2: Anonymous
Vaccines 2022, 10(3), 418; https://doi.org/10.3390/vaccines10030418
Submission received: 30 January 2022 / Revised: 3 March 2022 / Accepted: 4 March 2022 / Published: 10 March 2022
(This article belongs to the Special Issue Vaccines: 10th Anniversary)

Round 1

Reviewer 1 Report

This is a nice and well-written review article. 

However, I am concerned about chapter 4 that give the impression that inactivated vaccine have negative off-target effects while live vaccines positive. I am aware that there are examples for this from epidemiological studies but the data is not sufficient to give this general statement. Another point of concern is that most or all reported negative off-target effects were from the group of Peter Aaby. It does not mean that they are wrong but given the importance of vaccination, it is important to carefully address these issues with future immunological and epidemiological investigations. Furthermore, the negative off-target effects were, to my knowledge, only observed in high children mortality regions and again general conclusions are too risky at this point. I suggest therefore to keep the focus on the rotavirus vaccines, and simply mention that off-target effects could also possible citing e.g. an epidemiological study and mentioning DTP as an example. 

Also, the sex differences that are addressed are citing 4 review articles by one of the authors (66-68). Either this review simply refers that the topic has been reviewed elsewhere or cites the original works.

Author Response

Dear Reviewer 1,

We are grateful for your  constructive and valuable comments that have enhanced the value of our  manuscript. We have made the requested corrections in the attached detailed list of our Point-by-point responses.

Many thanks,

Khuzwayo 

Author Response File: Author Response.pdf

Reviewer 2 Report

Please see attached the comments.

Comments for author File: Comments.pdf

Author Response

Dear Reviewer 2,

We are grateful for your  constructive and valuable comments that have enhanced the value of our  manuscript. We have made the requested corrections in the attached detailed list of our Point-by-point responses.

Many thanks,

Khuzwayo 

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

No additional comment.

Author Response

No further suggestions made by the reviewer so no point-by-point response provided.

Back to TopTop